- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 259693, 9 pages
All-trans-Retinoic Acid Ameliorated High Fat Diet-Induced Atherosclerosis in Rabbits by Inhibiting Platelet Activation and Inflammation
1Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Anhui 230022, China
2Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Anhui 230601, China
3Laboratory of Molecular Biology, Anhui Medical University, Anhui 230032, China
Received 2 November 2011; Revised 21 December 2011; Accepted 21 December 2011
Academic Editor: Saulius Butenas
Copyright © 2012 Birong Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. I. Axel, A. Frigge, J. Dittmann et al., “All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells,” Cardiovascular Research, vol. 49, no. 4, pp. 851–862, 2001.
- J. M. Miano, S. Topouzis, M. W. Majesky, and E. N. Olson, “Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells,” Circulation, vol. 93, no. 10, pp. 1886–1895, 1996.
- H. Ou, J. Haendeler, M. R. Aebly et al., “Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells,” Circulation Research, vol. 87, no. 10, pp. 881–887, 2000.
- P. J. Wiegman, W. L. Barry, J. A. McPherson et al., “All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit: a favorable effect on vessel remodeling,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 1, pp. 89–95, 2000.
- C. Herdeg, M. Oberhoff, A. Baumbach et al., “Effects of local all-trans-retinoic acid delivery on experimental atherosclerosis in the rabbit carotid artery,” Cardiovascular Research, vol. 57, no. 2, pp. 544–553, 2003.
- J. M. Miano, L. A. Kelly, C. A. Artacho, T. A. Nuckolls, R. Piantedosi, and W. S. Blaner, “all-Trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery after balloon withdrawal injury,” Circulation, vol. 98, no. 12, pp. 1219–1227, 1998.
- A. J. Lusis, “Atherosclerosis,” Nature, vol. 407, no. 6801, pp. 233–241, 2000.
- C. J. L. Murray and A. D. Lopez, “Global mortality, disability, and the contribution of risk factors: global burden of disease study,” The Lancet, vol. 349, no. 9063, pp. 1436–1442, 1997.
- R. Riba, A. Nicolaou, M. Troxler, S. Homer-Vaniasinkam, and K. M. Naseem, “Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels,” Atherosclerosis, vol. 175, no. 1, pp. 69–75, 2004.
- M. Y. Hu, Y. L. Li, C. H. Jiang, Z. Q. Liu, S. L. Qu, and Y. M. Huang, “Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits,” Nutrition, vol. 24, no. 10, pp. 1030–1038, 2008.
- P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002.
- P. C. Burger and D. D. Wagner, “Platelet P-selectin facilitates atherosclerotic lesion development,” Blood, vol. 101, no. 7, pp. 2661–2666, 2003.
- Z. Zhai, J. Wu, X. Xu et al., “Fibrinogen controls human platelet fibronectin internalization and cell-surface retention,” Journal of Thrombosis and Haemostasis, vol. 5, no. 8, pp. 1740–1746, 2007.
- J. N. George, R. M. Lyons, and R. K. Morgan, “Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion,” Journal of Clinical Investigation, vol. 66, no. 1, pp. 1–9, 1980.
- J. Öckinger, P. Stridh, A. D. Beyeen et al., “Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis,” Genes and Immunity, vol. 11, no. 2, pp. 142–154, 2010.
- F. Rezaee, A. Maas, M. P. M. De Maat, J. H. Verheijen, and J. Koopman, “Effect of genetic background and diet on plasma fibrinogen in mice. Possible relation with susceptibility to atherosclerosis,” Atherosclerosis, vol. 164, no. 1, pp. 37–44, 2002.
- H. Yang, S. Lang, Z. Zhai et al., “Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression,” Blood, vol. 114, no. 2, pp. 425–436, 2009.
- H. Li, M. Dai, and W. Jia, “Paeonol attenuates high-fat-diet-induced atherosclerosis in rabbits by anti-inflammatory activity,” Planta Medica, vol. 75, no. 1, pp. 7–11, 2009.
- K. Park, D. G. Lee, S. W. Kim, and J. S. Paick, “Dimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis,” International Journal of Impotence Research, vol. 21, no. 4, pp. 228–234, 2009.
- N. Papageorgiou, D. Tousoulis, G. Siasos, and C. Stefanadis, “Is fibrinogen a marker of inflammation in coronary artery disease?” Hellenic Journal of Cardiology, vol. 51, no. 1, pp. 1–9, 2010.
- M. J. Benson, K. Pino-Lagos, M. Rosemblatt, and R. J. Noelle, “All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1765–1774, 2007.
- M. S. Tallman, J. W. Andersen, C. A. Schiffer et al., “All-trans-retinoic acid in acute promyelocytic leukemia,” New England Journal of Medicine, vol. 337, no. 15, pp. 1021–1028, 1997.
- M. S. Tallman, J. W. Andersen, C. A. Schiffer et al., “All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol,” Blood, vol. 100, no. 13, pp. 4298–4302, 2002.
- S. Tehrani, F. Mobarrez, A. Antovic et al., “Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia,” Thrombosis Research, vol. 126, no. 3, pp. e225–e231, 2010.
- S. Ramström, K. V. Öberg, F. Åkerström, C. Enström, and T. L. Lindahl, “Platelet PAR1 receptor density-correlation to platelet activation response and changes in exposure after platelet activation,” Thrombosis Research, vol. 121, no. 5, pp. 681–688, 2008.
- H. Schwertz, G. A. Zimmerman, and A. S. Weyrich, “Fibrinogen selects selectins,” Blood, vol. 114, no. 2, p. 234, 2009.
- Z. Zhai, J. Wu, X. Xu, et al., “From mice to men: lessons from intravital microscopy thrombosis model and hypofibrinogenemia patients-roles of vWF, fibrinogen, and fibronectin in thrombus formation,” National Research Forum for Young Investigators in Circulatory and Respiratory Health May, pp. 6–9, 2004.
- F. K. Keating, H. L. Dauerman, D. A. Whitaker, B. E. Sobel, and D. J. Schneider, “Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin,” Thrombosis Research, vol. 118, no. 3, pp. 361–369, 2006.
- X. Xu, J. Wu, Z. Zhai et al., “A novel fibrinogen Bβ chain framshift mutation in a patient with severe congenital hypofibrinogenaemia,” Thrombosis and Haemostasis, vol. 95, no. 6, pp. 931–935, 2006.
- K. J. Woollard and J. Chin-Dusting, “Therapeutic targeting of P-selectin in atherosclerosis,” Inflammation and Allergy, vol. 6, no. 1, pp. 69–74, 2007.
- A. Tailleux, A. Gozzo, G. Torpier et al., “Increased susceptibility of low-density lipoprotein to ex vivo oxidation in mice transgenic for human apolipoprotein B treated with 1 melatonin-related compound is not associated with atherosclerosis progression,” Journal of Cardiovascular Pharmacology, vol. 46, no. 3, pp. 241–249, 2005.
- P. A. Witt-Enderby, N. M. Radio, J. S. Doctor, and V. L. Davis, “Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy,” Journal of Pineal Research, vol. 41, no. 4, pp. 297–305, 2006.
- A. C. Barreto, N. Y. Maeda, R. P. S. Soares, C. Cícero, and A. A. Lopes, “Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled study,” Brazilian Journal of Medical and Biological Research, vol. 41, no. 8, pp. 657–663, 2008.
- R. Kleemann, H. M. G. Princen, J. J. Emeis et al., “Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin,” Circulation, vol. 108, no. 11, pp. 1368–1374, 2003.
- T. J. Stalker, A. M. Lefer, and R. Scalia, “A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid,” British Journal of Pharmacology, vol. 133, no. 3, pp. 406–412, 2001.
- Z. S. Huang, C. L. Zeng, L. J. Zhu, L. Jiang, N. Li, and H. Hu, “Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase,” Journal of Thrombosis and Haemostasis, vol. 8, no. 6, pp. 1383–1393, 2010.
- D. M. Wuttge, A. Romert, U. Eriksson, H. Törmä, G. K. Hansson, and A. Sirsjö, “Induction of CD36 by all-trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis,” The FASEB Journal, vol. 15, no. 7, pp. 1221–1223, 2001.